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Abstract.
The main purpose of this study is to describe how negative emotions were
investigated in the sphere of dermatological diseases, in order (1) to summarize
literature trends about skin disorders and emotions, (2) to highlight any
imbalances between the most studied and neglected emotions, (3) and to
offer directions for future research. A computerized literature search provided
41 relevant and potentially eligible studies. Results showed that the study of
emotions in skin disease is limited to Sadness/depression and Fear/anxiety.
The emotions of Anger and Disgust have been poorly explored in empirical
studies, despite they could be theoretically considered a vulnerability factor for
the development of skin disorders and the dermatological extreme consequences,
as negative emotionality toward self and the pathological skin condition. The
bibliometric qualitative analysis with VOSViewer software revealed that the
majority of the studies have been focused on the relationships between vitiligo
and Sadness/depression, dermatitis and Fear/anxiety, psoriasis, and Anger,
suggesting the need of future research exploring Disgust and, in general, a wider
emotional spectrum.
Resumen.
El objetivo principal de este estudio fue describir cómo se han investigado las
emociones negativas en el ámbito de las enfermedades dermatológicas, con
el fin de (1) resumir las tendencias de la literatura sobre las enfermedades de
la piel y las emociones, (2) para resaltar las diferencias entre las emociones
más estudiados y las más descuidadas y (3) ofrecer direcciones para futuras
investigaciones. Una búsqueda bibliográfica computarizada proporcionó 41
estudios relevantes y potencialmente elegibles. Los resultados mostraron
que el estudio de las emociones en la enfermedad de la piel se limita a
Tristeza/depresión y Miedo/ansiedad. Las emociones de la ira y el asco han sido
poco exploradas en estudios empíricos, a pesar de que teóricamente podrían
considerarse un factor de vulnerabilidad para el desarrollo de enfermedades de
la piel y las consecuencias dermatológicas extremas, como la emocionalidad
negativa hacia uno mismo y la condición patológica de la piel. El análisis
cualitativo bibliométrico con el software VOSViewer reveló que la mayoría de los
estudios se han centrado en las relaciones entre vitiligo y Tristeza/depresión,
dermatitis y Miedo/ansiedad, psoriasis e Ira, lo que sugiere la necesidad de
futuras investigaciones que exploren asco y, en general, un espectro emocional
más amplio.
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1. Introduction
From the physiological point of view, the skin is an organ
strictly linked to emotional activities: redness, pallor,
sweating, itching can be consequences of somatic activa-
tion, expressing a range of affective feeling-states. The
relationship between psychological distress and skin al-
terations has always been a topic of great interest for
researchers and clinicians. Unlike many other organs in
the body, the human epidermis has an immediate reac-
tion to mental stress, so that several authors aimed to
demonstrate the so-called “brain-skin connection” (Paus,
Theoharides, & Arck, 2006; Arck et al., 2010). It was
found that mental, physical, and emotional stress defi-
nitely affects the skin and this may depend on several
reasons. In stressful conditions, in fact, hormones relapse
encourages inflammation and the decreasing blood flow
to the skin (Dhabhar, 2000), irritating the skin nerves
and increasing inflammation or allergic reactions, with
systemic alterations of neuroendocrine and immunolog-
ical parameters (Pavlovic et al., 2008). Furthermore,
skin recruits the immune system to fight, dysregulating
the innate immune response and causing inflammations
such as Rosacea, Acne, and Psoriasis (Yamasaki & Gallo,
2009). As a consequence, triggering a vicious circle,
natural moisturizing factors, and plumping lipids pro-
duction decline and skin healing, repair, and restoration
processes are delayed (Eming, Krieg, & Davidson, 2007).
The connection between skin and mind has deep
roots and is the object of a specific clinic and research
field called Psychodermatology. Research hypothesis
has arisen spontaneously on the basis of careful obser-
vation of clinical data in medical settings and active
collaboration between dermatologists, psychiatrists and
psychologists. In the last twenty years, a number of der-
matological studies have shown that people affected by a
skin disorder often have a related psychological problem.
For example, Gupta and Gupta (2001) have observed
that patients with dermatological diseases show high
rates of comorbid Major Depressive Disorder (MDD),
Obsessive Compulsive Disorder (OCD), Body Dysmor-
phic Disorder, Social Phobia, and Post-Traumatic Stress
Disorder (PTSD), which required prescriptions for anxi-
olytic and antidepressant medications. Picardi, Abeni,
Melchi, Puddu, and Pasquini (2000) showed that the
prevalence of emotional disorders was even 25.2% in
about 2500 outpatients of a dermatological clinic. More
specifically, a prevalence of more than 30% was found in
patients with acne, pruritus, urticaria and alopecia.
In the study carried on by Gieler, Niemeier, Kupfer,
Brosig, and Schill (2001), a survey was sent to 69 der-
matology hospitals. In nearly all dermatoses, with the
exception of hyperhidrosis and seborrheic eczema, the
authors found that the extent of emotional influences
was increased, compared to a similar study performed
ten years before. However, the most interesting result
was the discovery of a subpopulation of about 23% of
dermatology patients with psychosomatic disorders.
Fritzsche et al. (2001), using the ICD-10 criteria
for the assessment of mental disorders, found mental,
emotional, and behavioral disorders –of which the most
frequent were mood and anxiety disorders– in 46% of
86 dermatological patients. Depression and anxiety, in
fact, are mostly risk factors for several skin diseases, as
can be seen in empirical studies on psoriasis vulgaris
(Devrimci-Ozguven, Kundakci, Kumbasar, & Boyvat,
2000).
Furthermore, there are some review studies that
have sought to establish relationships between psychi-
atric disorders and skin disorders. Buljan, Buljan, and
Situm (2005), arguing that the treatment of psycho-
dermatologic disorders is almost impossible without a
holistic team approach involving psychiatrist, dermatol-
ogist and psychologist, proposed a review about psycho-
dermatologic disorders, the psychosomatic disorders, pri-
mary psychiatric disorders, and secondary psychiatric
disorders. The review conclusion is that psychophar-
macologic treatment with anxiolytics, antidepressants,
antipsychotics, and mood stabilizers can be prescribed
by the dermatologist after consulting the psychiatrist.
Even Yadav, Narang, and Kumaran (2013) presented
a comprehensive review of salient features and treat-
ment updates in primary psychiatric dermatoses and
also discussed the secondary psychiatric morbidity. The
authors’ aim was to allow the dermatologist to be able to
initiate basic pharmacotherapy, to know about various
non-pharmacological treatments, such as psychotherapy,
and the right time to refer the patient to the psychiatrist.
Again, Tareen and Tareen (2015) described how ma-
jor affective disorders (such as major depression and
bipolar disorders), anxiety spectrum disorders (such as
social phobia and obsessive-compulsive disorder), and
some commonly encountered personality disorders are
frequently encountered in patients with skin conditions,
often complicating the treatment plan and creating a
viscous cycle where both disease processes keep perpetua-
ting each other.
More recently, Krooks, Weatherall, and Holland (2017)
discussed the etiology, epidemiology, clinical presentation,
diagnosis, and first-line treatment of specific primary
psychiatric causes of dermatologic conditions, writing a
review, useful as a guide for dermatologists to use while
prescribing atypical antipsychotics, selective serotonin
reuptake inhibitors, and tricyclic antidepressants and/or
cognitive behavioral therapy.
However, this literature review highlights some criti-
cal points. First of all, the common denominator is that
these studies are psychiatric/medical guidelines, focused
on the dermatological clinical practice and management,
and not on psychological features or to the comprehen-
sion of such mechanisms. As stated by Marshall, Taylor,
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and Bewley (2016) “patients who present to a psycho-
dermatology clinic usually believe they have a primary
skin problem (though this is not always the case)” (p.
31). Hence, there is the need of a study taking into ac-
count not only the nosographic aspects, or specific skin
disorders, but also the different types of skin disorders
and affective components, by including the entire range
of negative emotions, that is, sadness, fear, anger, and
disgust.
In the comprehension of patient suffering it should
be considered the link between skin, skin pathologies,
emotions, emotion expression, and emotion pathology.
Among skin disorders there is a psychosomatic quote.
Several psychodynamics theories suggest that the af-
fected skin represents the expression of a negative emo-
tion that is difficult for the individual to differentiate
and describe. However, the role played by emotions is
still unclear. It has not been yet established if negative
emotions can be considered a reaction to the pathologi-
cal condition or if, as stable response patterns, they can
increase the vulnerability for the development of skin
diseases. To reach this purpose a literature review is
necessary, in order to understand how negative emotions
have been studied hereinbefore, and to plan future studies
answering to this issue and helping clinicians to identify
the most effective treatments, both dermatological and
psychological, for these patients.
From these premises, the main aim of this study is
to describe how negative emotions were investigated in
the sphere of dermatological diseases, in order (1) to
summarize literature trends about skin disorders and
emotions, (2) to highlight any imbalances between the
most studied and the most neglected emotions, (3) and
to offer directions for future research.
2. Methods
A computerized literature searches of each item con-
tained in the ICD-10 classification for skin diseases –from
code L00 to L99– has been conducted on three scien-
tific article databases: Psyc-INFO, Web of Science, and
PubMed; moreover, in order to obtain even the most ob-
scure information, an electronic search on Google Scholar
has been carried on. For many skin disorders, the search
did not produce any relevant results to the field of emo-
tions. Figure 1 shows some of the terms inserted on
the literature search, representing the most popular re-
sults. Anyway, at the beginning of the research, each
skin disorder has been associated with each emotion.
Search limits restricted the results to: 1) research
articles published in English between 2000 and 2017 and
identified as empirical, epidemiological or longitudinal
studies; 2) researches conducted in a clinical sample; 3)
measuring negative emotions such as sadness, disgust,
anger and fear. As regards exclusion criteria, the search
did not include: a) Studies on Quality of Life (681); b)
Acne
Rosacea
Vitiligio
Psoriasis
Pruritus
Dermatitis
Urticaria
Alopecia
AND
Anxiety OR Fear
Depression OR Sadness
Anger OR Aggression
Disgust
Figure 1. Literature search terms.
Studies on caregivers of skin disordered patients (315);
c) Studies on children or adolescents (287); d) Dermato-
logical review studies, book chapters, dissertation, and
thesis (92). Following this second stage in the screen-
ing process, 41 studies provided relevant and potentially
eligible information for coding. According to the rec-
ommendation of Moher and the Prisma Group (2009),
Figure 2 shows the detailed flow chart with all research
steps and selection criteria.
For each publication, data regarding authors name,
year of publication, country of the study (population,
instruments language), the skin disorders observed, the
psychological instruments used, and the main results,
were entered in a spreadsheet (MS Excel 5.0) to allow the
construction of synthetic tables. To understand the rela-
tionship between skin and emotions we have divided the
studies on the basis of the primary emotions considered:
1) sadness; 2) fear; 3) anger; 4) disgust. However, despite
anxiety and depression are separate syndromes, they of-
ten co-occur. Hence, data of the studies that considered
both the diseases have been grouped, to avoid duplicate,
resulting in two tables. Finally, the qualitative data
analysis was conducted using VOSviewer 1.6.1, a soft-
ware tool for constructing and visualizing bibliometric
networks based on data downloaded from bibliographic
databases (Van Eck & Waltman, 2014). It produces a
bubble map through the analyses of words reported in
publications’ titles and abstracts. Each bubble repre-
sents a keyword or a phrase. The bubble size and color,
and inter-Buble distance indicate keyword’s frequency,
citation per publication (CPP) count, and frequency of
co-occurrence or corresponding terms in publications,
respectively (Van Eck & Waltman, 2014).
3. Results
3.1 Skin disorders, Sadness/Depression and Fear/
Anxiety
From a clinical point of view, sadness is the typical emo-
tion of loss, disappointment, separation, mourning. The
intensity of sadness depends on the value that the indi-
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Figure 2. Systematic Review Flow Chart.
vidual attributes to the loss, and the purposes which the
loss incurred compromise. The more it is considered in-
dispensable, irreplaceable and irretrievable what it lacks,
the more intense and prolonged will be the emotional
response of sadness (Lewis, Haviland-Jones, & Barrett,
2010). It is necessary to distinguish depression by “mo-
ments of sadness”, which may be present in the life of
every individual and usually have fairly obvious causes
and are characterized by a limited duration. Instead,
depression and the states of melancholy mood usually
are long lasting and accompanied by: a) low self-esteem;
b) loss of interest and/or pleasure in activities that are
normally pleasurable for the subject (anhedonia); c) lack
of motivation. In fact, depression is contemplated in the
international classifications of mood disorders (Wakefield
& Demazeux, 2016). Conceptually, it is impossible to
study the emotion of sadness as a primary emotion, as
the existing literature was mainly interested and focused
on the pathological expression of sadness, i.e., depres-
sion. Moreover, in the case of dermatological disorders
there may be a moment of physiological sadness linked
to the diagnosis, but the more interesting object is the
pathological, prolonged, and pervasive sadness, because
of the increased level of subjective suffering and psy-
chological pain. To date, too little is known about the
role played by this emotion. It is consolidated that the
two conditions co-occur, but it is not clear whether the
depression is the result of the failure to accept the diag-
nosis (i.e., a secondary disease) or if the depression, as
pre-existing condition, could increase the vulnerability
to the development of the somatic disorder.
A similar discussion regards the emotion of fear, an
immediate response to danger and undoubtedly a close
relative of anxiety. Both are the response to a “threat”.
However, even though anxiety and fear are similar in their
physiological manifestation (through physical symptoms
such as rapid heartbeat, difficulty in breathing, sweat-
ing, tightness, etc.), they differ substantially: fear is an
emotional reaction to a real danger, while anxiety is an
emotional reaction to a perceived danger (Perusini &
Fanselow, 2015). The studies analyzed refer to the latter
category, that is, to the pathological fear activation (anx-
iety). Up to date, we can only hypothesize that anxiety
may worsen the course of dermatological pathology or
may negatively influence the outcome and management
of the disease, which is often chronic. Moreover, is not
established if the anxiety trait can predispose to the de-
velopment of dermatological pathologies, although many
of them have been found in correlation.
Table 1 represents the characteristics of the studies
that explored Sadness/Depression and Fear/Anxiety in
Skin Disorders. As stated, depression and anxiety often
co-occur. We found 29 studies (only 8 measuring exclu-
sively depression), which explored depression and anxiety
in skin disordered patients. Studies increased in the last
years, but are homogeneous in different continents such
as Europe, Asia, and America, showing how the inci-
dence of depression and anxiety are similar in different
cultural and ethnic groups and also in the comparison
between different skin disorders. However, it can be ob-
served that the majority of the studies were focused on
vitiligo and psoriasis (65.5%), and often the two groups
are compared, with almost all studies reporting higher
levels of depression and anxiety in favor of the psoriatic
patients.
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Table 1
Characteristics of the researches studying Sadness/Depression and Fear/Anxiety in Skin Disorders
Author Country Skin disorder Sample Measure Results
Mattoo,
Handa,
Kaur,
Gupta,
and
Malhotra
(2001)
India Vitiligo andPsoriasis
113 patients
with vitiligo
(30.11±12.49)
and 103 with
psoriasis
(40.91±14.26)
ICD-10 psychiatric
diagnoses and
General Health
Questionnaire
(GHQ)
Positive cases of depressive episode
were 22% vs 29% in vitiligo and
psoriasis, respectively. Depression,
anxiety, and total psychopathology
levels were similar in the two GHQ
positive subgroups
Sharma,
Koranne,
and Singh
(2001)
India Vitiligo andPsoriasis
30 untreated
psoriasis and
vitiligo
patients aged
18–60 yrs
General Health
Questionnaire
(GHQ-H)
The prevalences of depression were
23.3% and 10% in psoriasis and
vitiligo respectively and anxiety
was observed in 3.3% of each group.
Esposito,
Saraceno,
Giunta,
Mac-
carone,
and
Chimenti
(2006)
Italy Psoriasis 2.391 patients
Center for
Epidemiological
Studies-Depression
Scale (CES-D)
questionnaire
Depressive
symptomatology was
observed in
1.482/2.391 patients
(62% overall)
Engin,
Uguz,
Yilmaz,
Özdemir,
and Mevli-
toglu
(2008)
Turkey
Chronic
idiopathic
urticaria (CIU)
73 patients
with CIU, and
34 healthy
subjects
matched for
age and sex
Beck Depression
Inventory (BDI), the
Beck Anxiety
Inventory (BAI)
When compared with healthy
controls, patients with CIU had
significantly higher BDI and BAI
scores
Ahmed,
Ahmed,
and
Nasreen
(2007)
Pakistan Vitiligo
100 patients
15-60 years
with a mean
age of 24.6
years
Psychiatric
Assessment Schedule
(PAS)
Major depressive illness (15), was
the most frequent psychiatric illness
followed by generalized anxiety
(10), mixed anxiety and depression,
social phobia, agarophobia and
sexual dysfunction.
Tabolli et
al. (2008) Italy
Pemphigus
vulgaris and
pemphigus
foliaceus
58 patients of
whom 47% <
50 years 53%
>50 years
36-item short form
health survey
(SF-36); ASQ anxiety
scale questionnaire;
Clinical Depression
Questionnaire
Patients with higher depression and
anxiety had a more severe degree of
mucocutaneous involvement
Ehsani,
Toosi,
Shahsha-
hani,
Arbabi,
and Noor-
moham-
madpour
(2009)
Iran
Neurotic
excoriation ,
trichotillomania,
delusion of
parasitosis and
dermatitis
artefacta
178 patients
with psycho-
cutaneous
disorder
(40.5±
15.6 years)
DSM-IV diagnostic
criteria
Mood and anxiety disorders were
common in patients with dermatitis
artefacta, as patients with neurotic
excoriation
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Dieris-
Hirche,
Gieler,
Kupfer,
and Milch
(2009)
Germany
Atopic
Dermatitis
(AD)
62 adult
atopic
dermatitis
patients and
62 healthy
controls
HADS-D
A significantly higher level of
suicidal ideation, anxiety and
depression was shown among
patients with atopic dermatitis
Abram,
Silm,
Maaroos,
and Oona
(2009)
Estonia Rosacea
70 consecutive
patients
(seekers) and
56 subjects
with rosacea
from
population
(non-seekers)
Mood Scale
questionnaire and
visual analogue scale
(VAS)
Higher mean VAS scores were not
related to severity of rosacea, but
were associated with the presence
of depressive symptoms among
seekers.
Layegh,
Arshadi,
Shahriari,
Pezeshkpour,
and
Nahidi
(2010)
Iran
Psoriasis, acne,
alopecia and
vitiligo
300 patients
with a mean
age of
26.55±10.81
years.
Beck depression
questionnaire
The prevalence rate of clinical
depression was found to be 47.4%
in patients with acne; 69.4% in
those with psoriasis; 70.1% in those
suffering from vitiligo; 50% in
diffuse alopecia areata; 60% in
universalis alopecia areata; 100% in
ophiasis alopecia areata and 68.3%
in patients with localized alopecia
areata.
Uhlenhake,
Yentzer,
and
Feldman
(2010)
North
Carolina Acne
Acne patients
aged 18 and
over
Total Resource
Utilization
Benchmarks0TM
Depression was two to three times
more prevalent in acne patients
than in the general population,
with a reported 8.8% of acne
patients having clinical depression.
Ghajarzadeh,
Ghiasi,
and
Kheirkhah
(2012)
Iran
psoriasis,
vitiligo, and
alopecia areata
300 patients
(100 with
alopecia
areata, 100
with psoriasis
and 100 with
vitiligo)
Beck Depression
Inventory (BDI),
SF-36 and
Dermatology Life
Quality Index
(DLQI)
Significant correlation was found
between DLQI and BDI in all
disease groups (r = 0.44,P < 0.001).
BDI scores were the highest in
psoriasis group but this difference
was not significant (P = 0.2).
Rashid et
al. (2011) Bangladesh
Vitiligo and
Psoriasis
50 patients
with psoriasis
35.32±10.05
years and
same number
of patients
with vitiligo
33.50±9.99
years and
were
compared
Diagnostic and
Statistical Manual
for Mental and
Behavioural
Disorders-Fourth
Edition)DSM-IV
The proportion of major depressive
disorders (MDD) was higher among
psoriasis patients 15(30.0%)
compared to vitiligo patients
04(8.0%). However, no statistical
difference was found between two
groups of patients in terms of
anxiety disorders (8% in psoriasis
and 12% in vitiligo patients).
Chan et al.
(2012) Singapore Vitiligo
145 vitiligo
patients aged
21+
Strucured
questionnaire
Among the patients, 17.2% (n= 25)
had been identified as depressed.
Alfani et
al. (2012) Italy Alopecia Areata
73 patients
and 73
controls
35.2±9.2 and
35.1±9.1
years,
respectively
Minnesota
Multiphasic
Personality Inventory
(MMPI-2)
Some scales (i.e. Depression,
Anxiety, Family relationships) were
higher for patients with alopecia
areata than for controls.
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Al-Harbi
(2013)
Saudi
Arabia Vitiligo
308 vitiligo
patients
Beck Depression
Inventory Scale
According to the Beck Depression
Scale, 54.5% were found to be
depressed, most with mild
depression.
Settineri,
Guarneri,
Saitta,
Mento,
and
Cannavò
(2013)
Italy
Seborrheic
dermatitis and
Psoriasis
Respectively:
33 with SD
(39.85±15.45)
and 36
psorisatic
(41.11±13.72)
years
Profile of Mood
States (POMS) and
the Toronto
Alexithymia Scale
TAS-20
Two different depressive profiles
emerged: psoriatic showed
symptoms of major depression, SD
patients to minor depression.
Sellami et
al. (2014) Tunisia
Alopecia areata
(AA)
50
patients-mean
age 32.92
years
Hospital Anxiety and
Depression scale
questionnaire,
Toronto Alexithymia
scale 20, andSeverity
of Alopecia Tool.
Depression and anxiety were
detected respectively in 38% and
62% of patients.
Duman,
Ozdemir,
Yucel, and
Akin
(2014)
Turkey Pilonidal sinus
205 patients:
107 operated
with primary
closure
(26.4±
4.5 years) and
98 Limberg
flap recon-
struction
(28.3±
4.8 years)
Beck Depression
Inventory; Beck
Anxiety Inventory;
Short Form 36
Mean Beck Depression Inventory
(19±6.13 vs. 16±4.90 p < 0.001)
and Beck Anxiety Inventory
(19±6.27 vs. 16±4.90 p < 0.001)
Dalgard et
al. (2015)
13
coun-
tries
Infections of the
skin and
subcoutaneaous
tissue
3635 patients
aged
47.2±17.9
years
Hospital Anxiety and
Depression Scale
Clinical depression =10.1%
Clinical Anxiety = 17.2%
Suicidal Ideation = 12.7%
Pärna,
Aluoja,
and Kingo
(2015)
Estonia Dermatitis andEczema
40 patients
with psoriasis,
40 with
eczema, 40
with acne, 15
with
seborrhoeic
dermatitis
and 40
healthy
controls (M=
38.9±14.5 )
Emotional State
Questionnaire
(EST-Q);
Dermatology Life
Quality Index
(DLQI);
RAND-36-item
HRQoL survey
Depression was similar in all
dermatological groups. Anxiety was
significantly higher in
dermatological patients, compared
to healthy controls (p= .005).
Kim et al.
(2015) Korea
Atopic
Dermatitis
(AD)
1517 (19.8±
1.0 years)
Korean Military
Multiphasic
Personality Inventory
(KMPI)
The adjusted odds ratios for
depression, anxiety, and
somatization were significantly
greater for individuals with AD
compared with those without AD.
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Cheng et
al. (2015) Taiwan
Atopic
Dermatitis
(AD)
8208 (32.60±
16.06years) ICD-9 Diagnosis
Higher incidence of depressive
disorder With
AD=273(4.32)Without
AD=48(0.74) <0.001 and Anxiety
disorders With AD=180(2.83)
Without AD=45(0.70) <0.001.
Konda et
al. (2015) India
Prurigo
Nodularis (PN)
39 patients
with PN
(27.87±17.6)
and 39 age
and gender
matched
healthy
controls
Pruritus Grading
Scale; Pittsburgh
Sleep Quality Index;
Hamilton rating scale
for depression
(HDRS)
Severity of depressive symptoms
was significantly higher in PN
patients (U = 350.5;p= 0.01).
Khattri,
Bist,
Arun, and
Mehta
(2015)
India Vitiligo
50 patients
with vitiligo
and 50
healthy
controls,aged
between 20
and 70 years
old
DSM-IV Axis I
Disorders (SCID-I),
Hospital Anxiety
Depression Scale
(HADS), Rosenberg
Self-Esteem Scale
(RSES), Liebowitz
Social Anxiety Scale
(LSAS) and Sheehan
Disability Scale
(SDS)
In comparison to healthy controls,
the rate of depression and anxiety
was found to be higher and mean
self-esteem score was found to be
lower in the vitiligo group. There
was no significant difference
between groups in terms of social
anxiety.
Egeberg,
Hansen,
Gislason,
and
Thyssen
(2016)
Denmark Rosacea
30.725 and
24.712
patients with
mild and
moderate-to-
severe rosacea
> 18 years
Data on 4.632.341
Danish citizens
Mild and moderate- to-severe
rosacea increased the risk of both
depression [IRR 1.89 (95% CI
1.82–1.96) and IRR 2.04 (95% CI
1.96–2.12)] and anxiety disorders
[IRR 1.80 (95% CI 1.75–1.86) and
IRR 1.98 (95% CI 1.91–2.05)].
Halioua,
Cribier,
Frey, and
Tan
(2017)
UK,
France,
Ger-
many
and
US
Rosacea 807 (31.3±14.5 years)
Online survey of the
general population
over 18 years of age
Those with FS were more likely to
avoid social situations (54.2% vs.
2.0%, p < 1.00E−10) and had a
higher rate of depression (36.7% vs.
21.1%, p < 1.00E−10).
Wojtyna,
Łakuta,
Marcinkiewicz,
Bergler-
Czop, and
Brzezińska-
Wcisło
(2017)
Poland Psoriasis
219 patients
with psoriasis,
aged 18–70
years
Beck Depression
Inventory, the
Appearance Schemas
Inventory-Revised,
the Berlin Social
Support Scales, and
the Distress
Thermometer
The main contributors to
depression were: female gender,
beliefs about appearance and its
salience to one’s self-worth, greater
psychological distress, and lower
levels of emotional social support.
Vernwal
(2017) India Vitiligo
100 vitiligo
patients and
100 controls
Hospital Anxiety and
Depression Scale
In comparison to healthy controls,
the psychiatric morbidity was
found to be significantly higher in
the vitiligo group (62% v/s 25%).
37%, 18%, and 7% vitiligo patients
suffered from Mixed anxiety and
depressive disorder, Depressive
disorder and Generalized anxiety
disorder respectively.
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3.2 Skin disorders and Anger/Aggression
For most of the theories, anger is the typical reaction
to both physical and psychological frustration and con-
striction. The causal relationship between frustration
and anger is quite complex. Other factors seem in fact
to be involved in the origins of anger emotion as, for
example, the responsibility and the awareness attributed
to the person or the situation that causes frustration or
constriction (Averill, 2012). The emotion of anger can be
defined as the reaction that follows a precise sequence of
events: a) a state of need; b) an object (living or nonliv-
ing) that is opposed to the realization of the need; c) the
attribution of intentionality to such object of opposing; d)
a lack of fear toward the frustrating object; e) the strong
intention to remove and attack the frustrating object;
f) an act of aggression implemented through the attack
(Boswell, 2016). Therefore, there are different kinds
of anger and specifically three: anger directed toward
others, self-directed or denied (Livingstone, Shepherd,
Spears, & Manstead, 2016).
Table 2 shows the studies related to Anger/Aggression
in Skin Disorders. The studies that have found the emo-
tion of anger, in association with skin diseases, is quite
low. Only 11 out of 41 studies (29%) addressed this
emotion, finding that this is one of the emotions mostly
experienced by people with psoriasis and atopic dermati-
tis, followed by urticaria and erythema, chronic idiopatic
urticaria, acne and vitiligo.
In particular, Conrad et al. (2008) measured alex-
ithymia (TAS-20), emotional distress (SCL-90-R). and
anger (STAXI) in skin-disordered patients, founding
that that chronic idiopathic urticaria (CIU) and pso-
riasis are associated with personality-based difficulties
in emotional regulation, particularly with regard to the
feeling of anger. However, it remains unclear if anger is
directed toward others, self-directed or denied. The high
prevalence of alexithymia seems connected with difficul-
ties in communicating anger and in both skin disorders,
the relationship between pruritus as a major symptom
of negative affectivity could explain anger towards self
and others.
3.3 Skin Disorders and Disgust
Disgust is an emotion characterized by a feeling of nausea,
revulsion, especially in respect of odors and flavors, and,
figuratively speaking, moral repulsion, intolerance, hate
with a strong psychological value. It is manifested by a
behavior tending to remove something or someone, and
from a physiological reaction, such as nausea and vom-
iting in response to dirt and contamination sensations
(Lateiner & Spatharas, 2016).
Over the years, not many authors have given their
contribution to the empirical study of the emotion of
disgust, but several studies show that disgust has the
function to keep us away from situations or substances
which could be dangerous, or from anything that is
abhorrent and dirty, including values, thoughts, people,
and, in some cases, even the self (Yoder, Widen, &
Russell, 2016). Although it can be assumed that disgust
plays a key role in the perception of body image and
dermatological disease, the studies on this topic are quite
low.
Unfortunately, only one study addressed the emotion
of disgust in patients with psoriasis. Lahousen et al.
(2016), in fact, investigated the differences psoriasis pa-
tients and skin-healthy controls concerning appraisal of
touching, shame and disgust in one hundred and seventy-
one patients with psoriasis and 171 skin healthy controls
who completed the Touch-Shame-Disgust-Questionnaire
(TSD-Q), obtaining that skin-related disgust and shame
were significantly higher in psoriasis patients. The study
of disgust is one of the most neglected, not only in the
field of psychology and psychiatry, but also in its ap-
plications in the dermatological context, presenting a
significantly low incidence even in the field of psycho-
dermatology.
4. Qualitative Analysis
Thanks to VOSviewer has been possible to analyze
a text that contained the main information of a paper
i.e. the disease and the associated primary emotion
studied. On the basis of data collected in the review of
the forty-one studies, a list has been formed. Figure 3
shows the bibliographic landscapes of the studies about
skin disorders and emotions. The more the colors are
close to red, the higher their occurrence and the closer
the words, the higher the co-occurrence.
The qualitative analysis provides visual information
on: 1) the proximity of vitiligo and sadness/depression;
2) the proximity of fear/anxiety and atopic dermatitis;
3) the proximity of psoriasis and anger; 4) the apparent
independence of disgust.
This visual analysis remarks on the findings discussed:
literature on emotions and skin diseases has been focused
on specific emotions, neglecting others. In particular,
the map highlights the imbalance between studies that
addressed depression and anxiety and studies that con-
sidered anger and/or disgust. In fact, still little is known
about the involvement of anger and its role as a predis-
posing factor and also as a secondary problem towards
the dermatological pathology. Furthermore, the emotion
of disgust is under-represented: in comparison to other
emotions, disgust is the most neglected, despite it is
undoubtedly involved. The individual can feel disgust
against his/her body (self-disgust) or can believe that
the other perceives him/her as disgusting.
5. Discussion
The present review study was aimed to describe in what
way negative emotions were investigated in the sphere
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Table 2
Characteristics of the researches studying Anger/Aggression in Skin Disorders
Author Country Skin disorder Sample Measure Results
Sayar,
Ugurad,
Kural,
and Acar
(2000)
Turkey Acne
31 acne
vulgaris
patients and
25 controls
Beck Depression
Inventory,
State-Trait Anxiety
Inventory, Rosenberg
Self-Esteem Scale,
and Spielberger
State-Trait Anger
Expression Inventory.
No significant difference was
detected on anger-related subscales
between the acne and control
groups.
Conrad et
al. (2008)
Germany
Chronic
idiopathic
urticaria (CIU)
and psoriasis
41 CIU
patients 44
psoriasis
patients and
49 healthy
controls
Alexithymia
(TAS-20), emotional
distress (SCL-90-R)
and anger (STAXI).
Anger was the only significant
predictor of pruritus severity in
CIU.
Linder et
al. (2009)
Italy Psoriasis
323 patients
(aged 18–85
years; mean
–SD age 51.2 –
28.7 years)
Interview and a
questionnaire
developed by
clinicians and
researchers
Psoriasis elicited anger, annoyance
at the inconvenience of the disease,
and irritation in approximately
50% of the patients
Kossakowska,
Cieś-
cińska,
Jaszewska,
and Placek
(2010)
Poland Vitiligo andPsoriasis
60 patients
with psoriasis
(n= 30) and
vitiligo
(n= 30) as
well as
healthy
persons
(n= 60)
matched
Watson and Greer’s
Courtauld Emotional
Control Scale and
Kossakowska’s
Chronic Patients
Questionnaire.
Psoriasis patients control negative
emotions more intensively than
healthy people. Vitiligo patients do
not differ in the control of negative
emotions compared with healthy
subjects.
Sampogna,
Tabolli,
and Abeni
(2012)
Italy Psoriasias 936 patients Skindex-29questionnaire
The emotions most frequently
experienced were: shame, anger,
Worry.
Takaki
and Ishii
(2013)
Japan
Atopic
Dermatitis
(AD)
43 adult
patients with
AD, 32 adults
with remission
from AD, and
63 adults
without AD
20–47 years
Anger expression
trait scale (AX)
Results indicated a significant
impact of anger suppression on
depression, in patients with AD.
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Altınöz,
Taşkın-
tuna,
Altınöz,
and Ceran
(2014)
Turkey
Chronic
spontaneous
urticaria (CSU)
and alopecia
areata (AA)
30 CSU 30
AA 30
controls
Hospital Anxiety and
Depression Scale and
Multi-Dimensional
Anger Inventory
More of the CSU patients were
observed to respond with excessive
anger to most situations, to have
high levels of anxiety anger and
passive aggressive interpersonal
Relationships.
Sarkar,
Sarkar,
Saha, and
Sarkar
(2014)
India Psoriasis
Forty-eight
patients of
psoriasis and
equal number
of healthy
controls
Self-reporting
questionnaire-24
(SRQ-24) and
skindex (A 61-item
survey questionnaire)
the most common psychiatric
morbidity in psoriasis patients was
anger (58.3%)
Altunay
and
Demirci
(2015)
Turkey Pruritus
40 patients
with a mean
age
46.55±13.20
years
State-Trait Anger
Expression Index
and the Mini
International
Neuropsychiatric
Interview (M.I.N.I)
Pruritus duration was correlated
with anger trait and anger-in
subscale scores in all patients.
Aydin et
al. (2017)
Turkey Psoriasis
Eighty-five
patients with
psoriasis and
86 healthy
controls
State-Trait
Expression Inventory
for Anger (STAXI)
and Roserberg
Self-esteem Scale
(RSES)
Reduced self-esteem and increased
anger levels are remarkable in
psoriasis patients.
(Coneo,
Thomp-
son, &
Lavda,
2017)
England Dermathologypatients
ninety-one
participant
Optimism (LOT-R),
perceptions of social
support (SFSSQ)
social acceptance,
fear of negative
Evaluation (FNE),
appearance concern
(CAR-
VAL/CARSAL),
appearance
discrepancy PADQ),
social comparison
(INCOMM) and
wellbeing (HADS) on
aggression levels
(RAQ)
Anxiety was also found to have a
significant positive relationship
with aggression
(β = 0.356, t= 2.564,p= 0.01).
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Figure 3. Bibliometric landscape of primary emotions and skin diseases.
of dermatological diseases, in order to highlight any pos-
sible imbalances between the most studied and the most
neglected emotions, to identify a possible association
model between the type of dermatological condition and
the emotion studied, and to offer cues for future research.
Clinical observation suggested that dermatological
patients live an intense emotional activation. From the
moment of the received diagnosis they have to face psy-
chological difficulties and have to manage disease accep-
tance and therapy management. This can raise different
reactions in the individual: from depression for the loss
of health, to anxiety for symptoms worsening, to anger
(why me?), until disgust towards pustule, desquamation,
rash, in other terms, against his/her own skin and body.
The loss of a healthy and attractive image can severely
impair the relationships with the body image and with
others. Studies on quality of life, despite interesting and
useful, do not cover or explain the aspects more related
to the inner emotional experience. To reach this purpose,
i.e., to understand how negative emotions are declined
among skin disordered patients, a review was necessary
as a first step in the comprehension of the psychological
functioning.
The present review suggests –despite taking into ac-
count that studies are published from one to two years
after their actual implementation– an increasing interest,
over the last five years, by authors who explored the
role of emotions in skin diseases, or more likely their
emotional consequences. It is increasingly evident the
impact of the psychosomatic medicine, the collaboration
between dermatologists, psychiatrists, and psychologists,
and the vision of the disorder in the psyche-soma unit
(Muscatello, Bruno, Scimeca, Pandolfo, & Zoccali, 2014;
Rizzo et al., 2018). However, the interest on negative
emotions in skin disorders reveals some contradiction
and imbalance. For example, we observed that the explo-
ration of the emotional aspects has been more successful
for some diseases such as psoriasis, dermatitis and vi-
tiligo. This may depend on the epidemiology of the
disease and thus on the rarity or representativeness of
the observations, or from a possible greater interest for
the diseases in which the psychological implications are
more observable. For example, the incidence of psori-
asis in adults varies from 78.9/100,000 person-years in
the United States to 230/100,000 person-years in Italy.
The occurrence of psoriasis varies also according to age
and geographic region, being more frequent in countries
more distant from the equator and in the adult age
range (Parisi, Symmons, Griffiths, & Ashcroft, 2013)
while the worldwide incidence of pemphigus is 0.75-5
cases/1,000,000 per year. Most cases of PV in North
America, Europe and Asia are sporadic, with a higher
incidence among Ashkenazi Jews, with an estimate of 1.6
per 100,000 populations per year in Jerusalem (Femiano,
2007).
The imbalance of the epidemiology of skin diseases
fails to explain the imbalance in the study of primary
emotions, which was found rather inhomogeneous.
Most of the studies have shown consistent results.
For example, we have found that: a) sadness was studied
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in terms of depression and, therefore, in its pathologi-
cal manifestation and not physiological; b) most of the
studies addressed the fear in terms of anxiety, or a reac-
tion to a perceived danger; c) many of the studies that
have studied depression have found an association with
anxiety, as already consolidated in the literature.
While other studies raise some controversial issues.
Results show that the emotion of disgust is considered
involved in dermatological disorders by different authors,
but is not sufficiently represented on the side of em-
pirical exploration. In other words, the authors argue
that disgust is undoubtedly associated with, for example,
papulosquamous or bullous diseases as a theoretical as-
sumption, but empirical studies on clinical samples and
plausibly appropriate tools for measuring the emotion of
disgust are almost completely unavailable (Settineri &
Mento, 2014).
The study of the emotion of anger, on the other hand,
resulted very limited. It becomes difficult to determine
whether or not this emotion is involved in skin diseases,
as it would suggest the clinical observation. The collected
data must take into account a possible bias: when the
emotion of anger appears in the studies cited, could be
the result of variability due to chance (e.g., an upstream
selection of the variable in the research design, a lack of
publication of studies that disconfirm the involvement
of anger in skin diseases, etc.). For these reasons, future
studies on the role of anger and disgust in dermatological
diseases would be advantageous.
6. Limitations
Of course, this review has also several limitations. Having
included some reviews, it is possible that the number
of studies dealing with depression and anxiety has been
underestimated. However, this could slightly modify
results, since depression and anxiety resulted as the most
studied among skin problems.
On the contrary, some of the studies cited also an-
alyzed the relationship between skin disorders and the
feelings of shame or guilt. These emotions have been
excluded because should need specific space of discussion
and scientific deepening. In clinical practice, we observe
that the patient is immersed in a mix of different emo-
tions with regard to the dermatological problem, because
it has an impact on the self-image and the social and
relational sphere. Every dermatological disease has its
particular features, some of them affect exposed body
areas, such as face or neck, and can generate intense
negative emotions not only towards self, but also against
other leading to avoidance of exposure, fear of judgement,
fear of intimacy, etc.
Besides, due to the disparity between the studies, but
also to the heterogeneity of the dermatological disorders
treated, it was not possible to conduct a meta-analysis.
Unfortunately, statistical conclusions and comparisons
are not applicable to this research. Hence, a problem
emerges with respect to the comparison of results. This
study has not mitigated the effects of measuring negative
emotions through different tools, which span from struc-
tured interview to self-report scales or questionnaires
vs. DSM-IV or ICD-10 diagnostic criteria. This makes
the discussion a narrative reflection of a qualitative na-
ture, supported by the visual analysis, as a bibliographic
landscape.
Finally, the failure to consult of search engines (e.g.,
Scopus) most appropriate for this kind of study, may
result in the exclusion of manuscripts useful for the
development of the revision theme.
7. Conclusion
We believe the most innovative points are two. The first
is that, to our knowledge, the present review considers
the whole negative emotional spectrum, i.e., not only
depression and anxiety, which are the most studied, but
also anger and disgust. The second point is the appli-
cation of an innovative method of bibliographic data
analysis software (VOS), resulting in a graphical repre-
sentation of the studies on the topic. This method allows
to create a sort of map, a landscape that immediately
suggests to the reader the “state of art”, arising new
issues and future research cues.
Dermatology is an interesting research field, a pref-
erential point of observation to understand the soma-
tization mechanisms and the mind-body relationship.
The link between emotional reactions and skin responses
is the background of the success of techniques such as
biofeedback, which allows visualizing the skin reactions
to a series of stimuli (Shenefelt, 2010). Since the emo-
tional reaction steps away from the skin (Damasio, 2003),
the visualization of one’s emotional reactions can help the
individual to recognize the importance of these reactions
and to manage them more effectively.
In conclusion, as well as in many other fields of
medicine, in which emotions intervene (Settineri, Rizzo,
Liotta, & Mento, 2017; Mento, Le Donne, Crisafulli,
Rizzo, & Settineri, 2017; Mento et al., 2015), the deep-
ening of the neglected aspects can foster a better un-
derstanding of the skin disorder and can be the basis of
therapeutic interventions increasingly targeted, such as
biofeedback technique and psychotherapy based on emo-
tion regulation and mindfulness based stress reduction.
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